{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:48:28Z","timestamp":1776926908644,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>N-glycosylation plays an important role in the structure and function of membrane and secreted proteins. The spike protein on the surface of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is heavily glycosylated and the major target for developing vaccines, therapeutic drugs and diagnostic tests. The first major SARS-CoV-2 variant carries a D614G substitution in the spike (S-D614G) that has been associated with altered conformation, enhanced ACE2 binding, and increased infectivity and transmission. In this report, we used mass spectrometry techniques to characterize and compare the N-glycosylation of the wild type (S-614D) or variant (S-614G) SARS-CoV-2 spike glycoproteins prepared under identical conditions. The data showed that half of the N-glycosylation sequons changed their distribution of glycans in the S-614G variant. The S-614G variant showed a decrease in the relative abundance of complex-type glycans (up to 45%) and an increase in oligomannose glycans (up to 33%) on all altered sequons. These changes led to a reduction in the overall complexity of the total N-glycosylation profile. All the glycosylation sites with altered patterns were in the spike head while the glycosylation of three sites in the stalk remained unchanged between S-614G and S-614D proteins.<\/jats:p>","DOI":"10.1038\/s41598-021-02904-w","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T06:02:38Z","timestamp":1638856958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry"],"prefix":"10.1038","volume":"11","author":[{"given":"Dongxia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore R.","family":"Keppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Solano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Baudys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asheley P.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian R.","family":"Woolfitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Pirkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"2904_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395, 497\u2013506 (2020).","journal-title":"Lancet (London, England)"},{"key":"2904_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"2904_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"2904_CR4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","volume":"1863","author":"Y Watanabe","year":"2019","unstructured":"Watanabe, Y., Bowden, T. A., Wilson, I. A. & Crispin, M. Exploitation of glycosylation in enveloped virus pathobiology. Biochim. Biophys. Acta 1863, 1480\u20131497 (2019).","journal-title":"Biochim. Biophys. Acta"},{"key":"2904_CR5","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","volume":"11","author":"Y Watanabe","year":"2020","unstructured":"Watanabe, Y. et al. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat. Commun. 11, 2688 (2020).","journal-title":"Nat. Commun."},{"key":"2904_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","volume":"28","author":"P Zhao","year":"2020","unstructured":"Zhao, P. et al. Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor. Cell Host Microbe 28, 586-601-e586 (2020).","journal-title":"Cell Host Microbe"},{"key":"2904_CR7","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","volume":"6","author":"L Casalino","year":"2020","unstructured":"Casalino, L. et al. Beyond shielding: The roles of glycans in the SARS-CoV-2 spike protein. ACS Cent. Sci. 6, 1722\u20131734 (2020).","journal-title":"ACS Cent. Sci."},{"key":"2904_CR8","doi-asserted-by":"publisher","first-page":"e61552","DOI":"10.7554\/eLife.61552","volume":"9","author":"Q Yang","year":"2020","unstructured":"Yang, Q. et al. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration. Elife 9, e61552 (2020).","journal-title":"Elife"},{"key":"2904_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber, B. et al. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812\u2013827819 (2020).","journal-title":"Cell"},{"key":"2904_CR10","doi-asserted-by":"publisher","first-page":"14031","DOI":"10.1038\/s41598-020-70827-z","volume":"10","author":"S Isabel","year":"2020","unstructured":"Isabel, S. et al. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. Sci. Rep. 10, 14031 (2020).","journal-title":"Sci. Rep."},{"key":"2904_CR11","unstructured":"C.D.C. SARS-CoV-2 Variant Classifications and Definitions. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/variant-surveillance\/variant-info.html (2021)."},{"key":"2904_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1001\/jama.2021.2294","volume":"325","author":"RP Walensky","year":"2021","unstructured":"Walensky, R. P., Walke, H. T. & Fauci, A. S. SARS-CoV-2 Variants of concern in the United States-challenges and opportunities. JAMA 325, 1037\u20131038 (2021).","journal-title":"JAMA"},{"key":"2904_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy, L. et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183, 739-751 e738 (2020).","journal-title":"Cell"},{"key":"2904_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182, 1284-1294 e1289 (2020).","journal-title":"Cell"},{"key":"2904_CR15","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1038\/s41467-020-19808-4","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun. 11, 6013 (2020).","journal-title":"Nat. Commun."},{"key":"2904_CR16","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.abe8499","volume":"370","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science 370, 1464\u20131468 (2020).","journal-title":"Science"},{"key":"2904_CR17","doi-asserted-by":"crossref","unstructured":"Plante, J.A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature (2020).","DOI":"10.1101\/2020.09.01.278689"},{"key":"2904_CR18","doi-asserted-by":"crossref","unstructured":"Zhou, B. et al. SARS-CoV-2 spike D614G change enhances replication and transmission. Nature (2021).","DOI":"10.1038\/s41586-021-03361-1"},{"key":"2904_CR19","doi-asserted-by":"crossref","unstructured":"Mansbach, R.A. et al. The SARS-CoV-2 Spike variant D614G favors an open conformational state. Sci. Adv. 7 (2021).","DOI":"10.1126\/sciadv.abf3671"},{"key":"2904_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.abf2303","volume":"372","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Science 372, 525\u2013530 (2021).","journal-title":"Science"},{"key":"2904_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.sbi.2020.10.028","volume":"68","author":"DR Thomas","year":"2020","unstructured":"Thomas, D. R. & Scott, N. E. Glycoproteomics: growing up fast. Curr. Opin. Struct. Biol. 68, 18\u201325 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2904_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coviro.2019.05.003","volume":"36","author":"AA Hargett","year":"2019","unstructured":"Hargett, A. A. & Renfrow, M. B. Glycosylation of viral surface proteins probed by mass spectrometry. Curr. Opin. Virol. 36, 56\u201366 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"2904_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/mas.21629","volume":"39","author":"JF Cipollo","year":"2020","unstructured":"Cipollo, J. F. & Parsons, L. M. Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships. Mass Spectrom. Rev. 39, 371\u2013409 (2020).","journal-title":"Mass Spectrom. Rev."},{"key":"2904_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-62703-146-2_1","volume":"951","author":"SM Patrie","year":"2013","unstructured":"Patrie, S. M., Roth, M. J. & Kohler, J. J. Introduction to glycosylation and mass spectrometry. Methods Mol. Biol. (Clifton, N.J.) 951, 1\u201317 (2013).","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"2904_CR25","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.3390\/molecules25184133","volume":"25","author":"D Witkowska","year":"2020","unstructured":"Witkowska, D. Mass spectrometry and structural biology techniques in the studies on the coronavirus-receptor interaction. Molecules (Basel, Switzerland) 25, 4133 (2020).","journal-title":"Molecules (Basel, Switzerland)"},{"key":"2904_CR26","doi-asserted-by":"crossref","unstructured":"Pujic, I. & Perreault, H. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins. Mass Spectr. Rev. (2021).","DOI":"10.1002\/mas.21679"},{"key":"2904_CR27","doi-asserted-by":"publisher","first-page":"e2000198","DOI":"10.1002\/pmic.202000198","volume":"21","author":"L Grenga","year":"2021","unstructured":"Grenga, L. & Armengaud, J. Proteomics in the COVID-19 battlefield: First semester check-up. Proteomics 21, e2000198 (2021).","journal-title":"Proteomics"},{"key":"2904_CR28","doi-asserted-by":"crossref","unstructured":"Kuo, C.W. et al. Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants. Glycobiology (2021).","DOI":"10.1101\/2021.07.21.453140"},{"key":"2904_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.abb9983","volume":"369","author":"Y Watanabe","year":"2020","unstructured":"Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science 369, 330\u2013333 (2020).","journal-title":"Science"},{"key":"2904_CR30","doi-asserted-by":"crossref","unstructured":"Shajahan, A., Supekar, N.T., Gleinich, A.S. & Azadi, P. Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology, cwaa042 (2020).","DOI":"10.1101\/2020.04.01.020966"},{"key":"2904_CR31","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Site-specific N-glycosylation characterization of recombinant SARS-CoV-2 spike proteins. Mol. Cel. Proteomics MCP (2020).","DOI":"10.1101\/2020.03.28.013276"},{"key":"2904_CR32","doi-asserted-by":"publisher","first-page":"560391","DOI":"10.1155\/2012\/560391","volume":"2012","author":"J Saba","year":"2012","unstructured":"Saba, J., Dutta, S., Hemenway, E. & Viner, R. Increasing the productivity of glycopeptides analysis by using higher-energy collision dissociation-accurate mass-product-dependent electron transfer dissociation. Int. J. Proteomics 2012, 560391 (2012).","journal-title":"Int. J. Proteomics"},{"key":"2904_CR33","doi-asserted-by":"publisher","first-page":"14730","DOI":"10.1021\/acs.analchem.0c03301","volume":"92","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Comprehensive analysis of the glycan complement of SARS-CoV-2 spike proteins using signature ions-triggered electron-transfer\/higher-energy collisional dissociation (EThcD) mass spectrometry. Anal. Chem. 92, 14730\u201314739 (2020).","journal-title":"Anal. Chem."},{"key":"2904_CR34","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.1038\/s41598-021-88809-0","volume":"11","author":"AP Chapman","year":"2021","unstructured":"Chapman, A. P. et al. Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies. Sci. Rep. 11, 9682 (2021).","journal-title":"Sci. Rep."},{"key":"2904_CR35","doi-asserted-by":"crossref","unstructured":"Allen, J.D. et al. Site-specific steric control of SARS-CoV-2 spike glycosylation. bioRxiv (2021).","DOI":"10.1101\/2021.03.08.433764"},{"key":"2904_CR36","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1021\/acs.jpcb.0c04553","volume":"124","author":"H Woo","year":"2020","unstructured":"Woo, H. et al. Developing a fully glycosylated full-length SARS-CoV-2 spike protein model in a viral membrane. J. Phys. Chem. B 124, 7128\u20137137 (2020).","journal-title":"J. Phys. Chem. B"},{"key":"2904_CR37","unstructured":"CHARMM-GUI. CHARMM-GUI Archive\u2014COVID-19 proteins library. http:\/\/www.charmm-gui.org\/docs\/archive\/covid192021 (2021)."},{"key":"2904_CR38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","volume":"29","author":"G Cerutti","year":"2021","unstructured":"Cerutti, G. et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe 29, 819-833 e817 (2021).","journal-title":"Cell Host Microbe"},{"key":"2904_CR39","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1016\/j.celrep.2020.108630","volume":"34","author":"SM Gobeil","year":"2021","unstructured":"Gobeil, S. M. et al. D614G mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1\/S2 junction. Cell Rep. 34, 108630 (2021).","journal-title":"Cell Rep."},{"key":"2904_CR40","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s13361-017-1701-4","volume":"28","author":"Q Yu","year":"2017","unstructured":"Yu, Q. et al. Electron-transfer\/higher-energy collision dissociation (EThcD)-enabled intact glycopeptide\/glycoproteome characterization. J. Am. Soc. Mass Spectrom. 28, 1751\u20131764 (2017).","journal-title":"J. Am. Soc. Mass Spectrom."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02904-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02904-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02904-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T13:05:58Z","timestamp":1670072758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02904-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02904-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.26.453787","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"assertion":[{"value":"23 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23561"}}